These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2671289)

  • 81. Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck.
    Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Horton J; Creech RH; Barnes LE
    Cancer; 1982 Dec; 50(11):2295-300. PubMed ID: 6754063
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
    Pivot X; Awada A; Gedouin D; Kerger J; Rolland F; Cupissol D; Caponigro F; Comella G; Lopez-Pousa JJ; Guardiola E; Giroux B; Gérard B; Schneider M
    Ann Oncol; 2003 Mar; 14(3):373-7. PubMed ID: 12598340
    [TBL] [Abstract][Full Text] [Related]  

  • 83. High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer.
    Rothenberg ML; Ostchega Y; Steinberg SM; Young RC; Hummel S; Ozols RF
    J Natl Cancer Inst; 1988 Nov; 80(18):1488-92. PubMed ID: 2846858
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Altered pharmacokinetics and clinical consequences of low dose methotrexate plus cisplatin in the treatment of advanced head and neck cancer.
    Milano G; Thyss A; Renée N; Vallicioni J; Santini J; Schneider M; Demard F
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):843-7. PubMed ID: 3770040
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
    Goren MP; Forastiere AA; Wright RK; Horowitz ME; Dodge RK; Kamen BA; Viar MJ; Pratt CB
    Cancer Chemother Pharmacol; 1987; 19(1):57-60. PubMed ID: 2880677
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.
    Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y
    Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of glutamine on methotrexate efficacy and toxicity.
    Rubio IT; Cao Y; Hutchins LF; Westbrook KC; Klimberg VS
    Ann Surg; 1998 May; 227(5):772-8; discussion 778-80. PubMed ID: 9605669
    [TBL] [Abstract][Full Text] [Related]  

  • 88. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity.
    Frei E; Blum RH; Pitman SW; Kirkwood JM; Henderson IC; Skarin AT; Mayer RJ; Bast RC; Garnick MB; Parker LM; Canellos GP
    Am J Med; 1980 Mar; 68(3):370-6. PubMed ID: 6965819
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The role of methotrexate in osteosarcoma.
    Grem JL; King SA; Wittes RE; Leyland-Jones B
    J Natl Cancer Inst; 1988 Jul; 80(9):626-55. PubMed ID: 3286880
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacokinetics of platinum in cancer patients treated with carboplatin in combination with high-dose methotrexate.
    el-Yazigi A; Amer M; Martin CR
    Pharm Res; 1989 Jun; 6(6):492-6. PubMed ID: 2668915
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial.
    Roussel A; Bleiberg H; Dalesio O; Jacob JH; Haegele P; Jung GM; Paillot B; Heintz JF; Gignoux M; Nasca S
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):67-72. PubMed ID: 2463980
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial.
    Tarpley JL; Chretien PB; Alexander JC; Hoye RC; Block JB; Ketcham AS
    Am J Surg; 1975 Oct; 130(4):481-6. PubMed ID: 1080961
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial.
    Higano CS; Livingston RB
    Cancer Chemother Pharmacol; 1989; 23(4):259-62. PubMed ID: 2647313
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The treatment of advanced bladder cancer with methotrexate and cis-platinum--a pharmacokinetic study.
    Kaye SB; McWhinnie D; Hart A; Deane RF; Billaert P; Welsh J; Milsted RV; Stuart JF; Calman KC
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):249-52. PubMed ID: 6368243
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum.
    Haim N; Kedar A; Robinson E
    Cancer Chemother Pharmacol; 1984; 13(3):223-5. PubMed ID: 6541532
    [TBL] [Abstract][Full Text] [Related]  

  • 96. High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.
    Monjanel S; Rigault JP; Cano JP; Carcassonne Y; Favre R
    Cancer Chemother Pharmacol; 1979; 3(3):189-96. PubMed ID: 527209
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Chemosensitivity test for head and neck cancers].
    Xu W; Liang M
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):210-3. PubMed ID: 9642344
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.
    Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y
    Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate.
    Schifeling DJ; George T; McGuirt F; Capizzi RL; Kamen BA
    Med Pediatr Oncol; 1994; 22(2):88-90. PubMed ID: 8259106
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sequential MTX and 5-FU: advance or myth?
    Coates A
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):131-3. PubMed ID: 3516706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.